Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR.

Fatobene G, Rocha V, St Martin A, Hamadani M, Robinson S, Bashey A, Boumendil A, Brunstein C, Castagna L, Dominietto A, Finel H, Chalandon Y, Kenzey C, Kharfan-Dabaja M, Labussière-Wallet H, Moraleda JM, Pastano R, Perales MA, El Ayoubi HR, Ruggeri A, Sureda A, Volt F, Yakoub-Agha I, Zhang MJ, Gluckman E, Montoto S, Eapen M.

J Clin Oncol. 2020 Feb 7:JCO1902408. doi: 10.1200/JCO.19.02408. [Epub ahead of print]

PMID:
32031876
2.

Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research.

Sánchez-Guijo F, García-Olmo D, Prósper F, Martínez S, Zapata A, Fernández-Avilés F, Toledo-Aral JJ, Torres M, Fariñas I, Badimón L, Labandeira-García JL, García-Sancho J, Moraleda JM; TerCel.

Cytotherapy. 2020 Jan;22(1):1-5. doi: 10.1016/j.jcyt.2019.11.001. Epub 2019 Dec 19. Review.

3.

Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma.

Paiva B, Puig N, Cedena MT, Rosiñol L, Cordón L, Vidriales MB, Burgos L, Flores-Montero J, Sanoja-Flores L, Lopez-Anglada L, Maldonado R, de la Cruz J, Gutierrez NC, Calasanz MJ, Martin-Ramos ML, Garcia-Sanz R, Martinez-Lopez J, Oriol A, Blanchard MJ, Rios R, Martin J, Martinez-Martinez R, Sureda A, Hernandez MT, de la Rubia J, Krsnik I, Moraleda JM, Palomera L, Bargay J, Van Dongen JJM, Orfao A, Mateos MV, Blade J, San-Miguel JF, Lahuerta JJ; GEM (Grupo Español de Mieloma)/PETHEMA (Programa Para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Group.

J Clin Oncol. 2019 Nov 26:JCO1901231. doi: 10.1200/JCO.19.01231. [Epub ahead of print]

PMID:
31770060
4.

Safety and Biodistribution of Human Bone Marrow-Derived Mesenchymal Stromal Cells Injected Intrathecally in Non-Obese Diabetic Severe Combined Immunodeficiency Mice: Preclinical Study.

Quesada MP, García-Bernal D, Pastor D, Estirado A, Blanquer M, García-Hernández AM, Moraleda JM, Martínez S.

Tissue Eng Regen Med. 2019 Jul 26;16(5):525-538. doi: 10.1007/s13770-019-00202-1. eCollection 2019 Oct.

PMID:
31624707
5.

Glioblastoma ablates pericytes antitumor immune function through aberrant up-regulation of chaperone-mediated autophagy.

Valdor R, García-Bernal D, Riquelme D, Martinez CM, Moraleda JM, Cuervo AM, Macian F, Martinez S.

Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20655-20665. doi: 10.1073/pnas.1903542116. Epub 2019 Sep 23.

6.

Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma.

Rosiñol L, Oriol A, Rios R, Sureda A, Blanchard MJ, Hernández MT, Martínez-Martínez R, Moraleda JM, Jarque I, Bargay J, Gironella M, de Arriba F, Palomera L, González-Montes Y, Martí JM, Krsnik I, Arguiñano JM, González ME, González AP, Casado LF, López-Anglada L, Paiva B, Mateos MV, San Miguel JF, Lahuerta JJ, Bladé J.

Blood. 2019 Oct 17;134(16):1337-1345. doi: 10.1182/blood.2019000241.

7.

Biological Effects of New Hydraulic Materials on Human Periodontal Ligament Stem Cells.

López-García S, Lozano A, García-Bernal D, Forner L, Llena C, Guerrero-Gironés J, Moraleda JM, Murcia L, Rodríguez-Lozano FJ.

J Clin Med. 2019 Aug 14;8(8). pii: E1216. doi: 10.3390/jcm8081216.

8.

Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy.

Jiménez-Ubieto A, Grande C, Caballero D, Yáñez L, Novelli S, Hernández-Garcia MT, Manzanares M, Arranz R, Ferreiro JJ, Bobillo S, Mercadal S, Galeo A, Jiménez JL, Moraleda JM, Vallejo C, Albo C, Pérez E, Marrero C, Magnano L, Palomera L, Jarque I, Rodriguez A, Lorza L, Martín A, Coria E, López-Guillermo A, Salar A, José Lahuerta J; GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) Cooperative Study Group.

Hematol Oncol Stem Cell Ther. 2019 Dec;12(4):194-203. doi: 10.1016/j.hemonc.2019.06.001. Epub 2019 Jul 9.

9.

Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.

Soria-Juan B, Escacena N, Capilla-González V, Aguilera Y, Llanos L, Tejedo JR, Bedoya FJ, Juan V, De la Cuesta A, Ruiz-Salmerón R, Andreu E, Grochowicz L, Prósper F, Sánchez-Guijo F, Lozano FS, Miralles M, Del Río-Solá L, Castellanos G, Moraleda JM, Sackstein R, García-Arranz M, García-Olmo D, Martín F, Hmadcha A, Soria B; Collaborative Working Group “Noma Project Team”.

Front Immunol. 2019 Jun 4;10:1151. doi: 10.3389/fimmu.2019.01151. eCollection 2019.

10.

Comparison of diffusion, cytotoxicity and tissue inflammatory reactions of four commercial bleaching products against human dental pulp stem cells.

Llena C, Collado-González M, García-Bernal D, Oñate-Sánchez RE, Martínez CM, Moraleda JM, Rodríguez-Lozano FJ, Forner L.

Sci Rep. 2019 May 23;9(1):7743. doi: 10.1038/s41598-019-44223-1.

11.

Gonadal Function after Busulfan Compared with Treosulfan in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplant.

Faraci M, Diesch T, Labopin M, Dalissier A, Lankester A, Gennery A, Sundin M, Uckan-Cetinkaya D, Bierings M, Peters AMJ, Garwer M, Schulz A, Michel G, Giorgiani G, Gruhn B, Locatelli F, Giardino S, Uyttebroeck A, Rialland F, Itäla-Remes M, Dreger P, Shaw PJ, Bordon V, Schlegel PG, Mellgren K, Moraleda JM, Patrick K, Schneider P, Jubert C, Lawitschka A, Salooja N, Basak GW, Corbacioglu S, Duarte R, Bader P; Pediatric and Transplant Complications Working Parties of the European Society for Blood and Marrow Transplantation.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1786-1791. doi: 10.1016/j.bbmt.2019.05.005. Epub 2019 May 11.

PMID:
31082473
12.

Imaging and bone marrow assessments improve minimal residual disease prediction in multiple myeloma.

Alonso R, Cedena MT, Gómez-Grande A, Ríos R, Moraleda JM, Cabañas V, Moreno MJ, López-Jiménez J, Martín F, Sanz A, Valeri A, Jiménez A, Sánchez R, Lahuerta JJ, Martínez-López J.

Am J Hematol. 2019 Aug;94(8):853-861. doi: 10.1002/ajh.25507. Epub 2019 Jun 9.

PMID:
31074033
13.

Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma.

López-Corral L, Caballero-Velázquez T, López-Godino O, Rosiñol L, Pérez-Vicente S, Fernandez-Avilés F, Krsnik I, Morillo D, Heras I, Morgades M, Rifon JJ, Sampol A, Iniesta F, Ocio EM, Martin J, Rovira M, Cabero M, Castilla-Llorente C, Ribera JM, Torres-Juan M, Moraleda JM, Martinez C, Vázquez A, Gutierrez G, Caballero D, San Miguel JF, Mateos MV, Pérez-Simón JA.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1703-1712. doi: 10.1016/j.bbmt.2019.04.026. Epub 2019 May 3.

PMID:
31054983
14.

Silk fibroin scaffolds seeded with Wharton's jelly mesenchymal stem cells enhance re-epithelialization and reduce formation of scar tissue after cutaneous wound healing.

Millán-Rivero JE, Martínez CM, Romecín PA, Aznar-Cervantes SD, Carpes-Ruiz M, Cenis JL, Moraleda JM, Atucha NM, García-Bernal D.

Stem Cell Res Ther. 2019 Apr 27;10(1):126. doi: 10.1186/s13287-019-1229-6.

15.

Chronic model of tympanic perforation in rats with mitomycin C and dexamethasone.

Esteban T, Atucha NM, Moraleda JM, García-Estañ J, Insausti CL, Moraleda-Deleyto J.

J Otol. 2019 Mar;14(1):12-16. doi: 10.1016/j.joto.2018.11.002. Epub 2018 Nov 10.

16.

The poor prognosis of low hypodiploidy in adults with B-cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients.

Ribera J, Granada I, Morgades M, Vives S, Genescà E, González C, Nomdedeu J, Escoda L, Montesinos P, Mercadal S, Coll R, González-Campos J, Abella E, Barba P, Bermúdez A, Gil C, Tormo M, Pedreño M, Martínez-Carballeira D, Hernández-Rivas JM, Orfao A, Martínez-López J, Esteve J, Bravo P, Garcia-Guiñon A, Debén G, Moraleda JM, Queizán JA, Ortín X, Moreno MJ, Feliu E, Solé F, Ribera JM; PETHEMA Group, Spanish Society of Haematology.

Br J Haematol. 2019 Jul;186(2):263-268. doi: 10.1111/bjh.15887. Epub 2019 Mar 27.

PMID:
30916384
17.

Evaluation of changes in ion release and biological properties of NeoMTA-Plus and Endocem-MTA exposed to an acidic environment.

Rodríguez-Lozano FJ, Collado-González M, López-García S, García-Bernal D, Moraleda JM, Lozano A, Forner L, Murcia L, Oñate-Sánchez RE.

Int Endod J. 2019 Aug;52(8):1196-1209. doi: 10.1111/iej.13107. Epub 2019 Mar 28.

PMID:
30828816
18.

Biological effects of acid-eroded MTA Repair HP and ProRoot MTA on human periodontal ligament stem cells.

Collado-González M, López-García S, García-Bernal D, Oñate-Sánchez RE, Tomás-Catalá CJ, Moraleda JM, Lozano A, Forner L, Rodríguez-Lozano FJ.

Clin Oral Investig. 2019 Oct;23(10):3915-3924. doi: 10.1007/s00784-019-02822-2. Epub 2019 Jan 25.

PMID:
30684060
19.

Cryopreserved amniotic membrane in the treatment of diabetic foot ulcers: a case series.

Valiente MR, Nicolás FJ, García-Hernández AM, Fuente Mora C, Blanquer M, Alcaraz PJ, Almansa S, Merino GR, Lucas MDL, Algueró MC, Insausti CL, Piñero A, Moraleda JM, Castellanos G.

J Wound Care. 2018 Dec 2;27(12):806-815. doi: 10.12968/jowc.2018.27.12.806.

PMID:
30557111
20.

GuttaFlow Bioseal promotes spontaneous differentiation of human periodontal ligament stem cells into cementoblast-like cells.

Rodríguez-Lozano FJ, Collado-González M, Tomás-Catalá CJ, García-Bernal D, López S, Oñate-Sánchez RE, Moraleda JM, Murcia L.

Dent Mater. 2019 Jan;35(1):114-124. doi: 10.1016/j.dental.2018.11.003. Epub 2018 Nov 19.

PMID:
30466731
21.

Human Wharton's jelly mesenchymal stem cells protect axotomized rat retinal ganglion cells via secretion of anti-inflammatory and neurotrophic factors.

Millán-Rivero JE, Nadal-Nicolás FM, García-Bernal D, Sobrado-Calvo P, Blanquer M, Moraleda JM, Vidal-Sanz M, Agudo-Barriuso M.

Sci Rep. 2018 Nov 2;8(1):16299. doi: 10.1038/s41598-018-34527-z.

22.

Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma.

Baptista MJ, Tapia G, Morgades M, Muncunill J, Muñoz-Marmol AM, Montoto S, Gribben JG, Calaminici M, Martinez A, Gonzalez-Farre B, Dlouhy I, González-Barca E, Terol MJ, Miralles P, Alcoceba M, Vall-Llovera F, Briones J, Abrisqueta P, Abella E, Provencio M, García-Ballesteros C, Moraleda JM, Sancho JM, Ribera JM, Mate JL, Navarro JT.

Leuk Lymphoma. 2019 Apr;60(4):1087-1091. doi: 10.1080/10428194.2018.1512711. Epub 2018 Oct 15. No abstract available.

PMID:
30322315
23.

Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report.

Sahebi F, Garderet L, Kanate AS, Eikema DJ, Knelange NS, Alvelo OFD, Koc Y, Blaise D, Bashir Q, Moraleda JM, Dreger P, Sanchez JF, Ciurea S, Schouten H, Shah NN, Verbeek M, Rösler W, Diez-Martin JL, Schoenland S, D'Souza A, Kröger N, Hari P.

Biol Blood Marrow Transplant. 2019 Feb;25(2):335-342. doi: 10.1016/j.bbmt.2018.09.018. Epub 2018 Sep 20.

24.

Production via good manufacturing practice of exofucosylated human mesenchymal stromal cells for clinical applications.

López-Lucas MD, Pachón-Peña G, García-Hernández AM, Parrado A, Sánchez-Salinas D, García-Bernal D, Algueró MDC, Martinez FI, Blanquer M, Cabañas-Perianes V, Molina-Molina M, Asín-Aguilar C, Moraleda JM, Sackstein R.

Cytotherapy. 2018 Sep;20(9):1110-1123. doi: 10.1016/j.jcyt.2018.07.001. Epub 2018 Aug 29.

PMID:
30170815
25.

Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment.

Jiménez-Ubieto A, Grande C, Caballero D, Yáñez L, Novelli S, Hernández-Garcia MT, Manzanares M, Arranz R, Ferreiro JJ, Bobillo S, Mercadal S, Galeo A, Jiménez JL, Moraleda JM, Vallejo C, Albo C, Pérez E, Marrero C, Magnano L, Palomera L, Jarque I, Martínez-Sánchez P, Martín A, Coria E, López-Guillermo A, Salar A, Lahuerta JJ; GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) Cooperative Study Group.

Hematol Oncol. 2018 Dec;36(5):765-772. doi: 10.1002/hon.2553. Epub 2018 Sep 12. No abstract available.

PMID:
30129233
26.

Preclinical Studies of the Biosafety and Efficacy of Human Bone Marrow Mesenchymal Stem Cells Pre-Seeded into β-TCP Scaffolds after Transplantation.

Gonzálvez-García M, Martinez CM, Villanueva V, García-Hernández A, Blanquer M, Meseguer-Olmo L, Oñate Sánchez RE, Moraleda JM, Rodríguez-Lozano FJ.

Materials (Basel). 2018 Aug 3;11(8). pii: E1349. doi: 10.3390/ma11081349.

27.

A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group.

Pardal E, Díez Baeza E, Salas Q, García T, Sancho JM, Monzón E, Moraleda JM, Córdoba R, de la Cruz F, Queizán JA, Rodríguez MJ, Navarro B, Hernández JA, Díez R, Vahi M, Viguria MC, Canales M, Peñarrubia MJ, González-López TJ, Montes-Moreno S, González-Barca E, Caballero D, Martín A; GELTAMO Spanish Collaborative Group.

Am J Hematol. 2018 Jul;93(7):867-873. doi: 10.1002/ajh.25107. Epub 2018 May 6.

28.

Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation.

Avivi I, Boumendil A, Finel H, Nagler A, de Sousa AB, Santasusana JMR, Vandenberghe E, Afanasyev B, Bordessoule D, Moraleda JM, Garcia EC, Pohlreich D, Garcia GG, Thomson K, Or R, Beelen D, Zuffa E, Giebel S, Berthou C, Salles G, Melpignano A, Montoto S, Dreger P.

Bone Marrow Transplant. 2018 Aug;53(8):1001-1009. doi: 10.1038/s41409-017-0063-7. Epub 2018 Feb 20.

PMID:
29463854
29.

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model.

Giraldo A, Talavera López J, Fernandez-Del-Palacio MJ, García-Nicolás O, Seva J, Brooks G, Moraleda JM.

J Vis Exp. 2018 Jan 21;(131). doi: 10.3791/56699.

30.

Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry.

Jiménez-Ubieto A, Grande C, Caballero D, Yáñez L, Hernández-Garcia MT, Novelli S, Arranz R, Ferreiro JJ, Bobillo S, Mercadal S, Galeo A, Jiménez JL, Moraleda JM, Vallejo C, Albo C, Pérez E, Marrero C, Magnano L, Palomera L, Jarque I, Martínez-Sánchez P, Martín A, Coria E, López-Guillermo A, Salar A, Lahuerta JJ; GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) Cooperative Study Group.

Bone Marrow Transplant. 2018 Jun;53(6):780-783. doi: 10.1038/s41409-018-0096-6. Epub 2018 Jan 23. No abstract available.

PMID:
29362504
31.

Amniotic membrane promotes focal adhesion remodeling to stimulate cell migration.

Bernabé-García Á, Liarte S, Moraleda JM, Castellanos G, Nicolás FJ.

Sci Rep. 2017 Nov 10;7(1):15262. doi: 10.1038/s41598-017-15509-z.

32.

Biocompatibility of New Pulp-capping Materials NeoMTA Plus, MTA Repair HP, and Biodentine on Human Dental Pulp Stem Cells.

Tomás-Catalá CJ, Collado-González M, García-Bernal D, Oñate-Sánchez RE, Forner L, Llena C, Lozano A, Moraleda JM, Rodríguez-Lozano FJ.

J Endod. 2018 Jan;44(1):126-132. doi: 10.1016/j.joen.2017.07.017. Epub 2017 Nov 1.

PMID:
29079052
33.

Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma.

Jiménez-Ubieto A, Grande C, Caballero D, Yáñez L, Novelli S, Hernández MT, Manzanares M, Arranz R, Ferreiro JJ, Bobillo S, Mercadal S, Galego A, Jiménez JL, Moraleda JM, Vallejo C, Albo C, Pérez E, Marrero C, Magnano L, Palomera L, Jarque I, Coria E, Rodriguez A, Martín A, López-Guillermo A, Salar A, Lahuerta JJ; GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) cooperative study group.

Cancer Med. 2017 Dec;6(12):2766-2774. doi: 10.1002/cam4.1217. Epub 2017 Oct 26.

34.

Glioblastoma progression is assisted by induction of immunosuppressive function of pericytes through interaction with tumor cells.

Valdor R, García-Bernal D, Bueno C, Ródenas M, Moraleda JM, Macian F, Martínez S.

Oncotarget. 2017 Aug 2;8(40):68614-68626. doi: 10.18632/oncotarget.19804. eCollection 2017 Sep 15.

35.

High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party.

Akhtar S, Montoto S, Boumendil A, Finel H, Masszi T, Jindra P, Nemet D, Fuhrmann S, Beguin Y, Castagna L, Ferrara F, Capria S, Malladi R, Moraleda JM, Bloor A, Ghesquières H, Meissner J, Sureda A, Dreger P.

Am J Hematol. 2018 Jan;93(1):40-46. doi: 10.1002/ajh.24927. Epub 2017 Nov 9.

36.

Comparative analysis of the biological effects of the endodontic bioactive cements MTA-Angelus, MTA Repair HP and NeoMTA Plus on human dental pulp stem cells.

Tomás-Catalá CJ, Collado-González M, García-Bernal D, Oñate-Sánchez RE, Forner L, Llena C, Lozano A, Castelo-Baz P, Moraleda JM, Rodríguez-Lozano FJ.

Int Endod J. 2017 Dec;50 Suppl 2:e63-e72. doi: 10.1111/iej.12859. Epub 2017 Oct 6.

PMID:
28891221
37.

Assessment of biodistribution using mesenchymal stromal cells: Algorithm for study design and challenges in detection methodologies.

Reyes B, Coca MI, Codinach M, López-Lucas MD, Del Mazo-Barbara A, Caminal M, Oliver-Vila I, Cabañas V, Lope-Piedrafita S, García-López J, Moraleda JM, Fontecha CG, Vives J.

Cytotherapy. 2017 Sep;19(9):1060-1069. doi: 10.1016/j.jcyt.2017.06.004. Epub 2017 Jul 19.

PMID:
28734679
38.

Amniotic membrane stimulates cell migration by modulating transforming growth factor-β signalling.

Ruiz-Cañada C, Bernabé-García Á, Liarte S, Insausti CL, Angosto D, Moraleda JM, Castellanos G, Nicolás FJ.

J Tissue Eng Regen Med. 2018 Mar;12(3):808-820. doi: 10.1002/term.2501. Epub 2017 Oct 24.

PMID:
28621502
39.

Biological effects of silk fibroin 3D scaffolds on stem cells from human exfoliated deciduous teeth (SHEDs).

Collado-González M, Pecci-Lloret MP, García-Bernal D, Aznar-Cervantes S, Oñate-Sánchez RE, Moraleda JM, Cenis JL, Rodríguez-Lozano FJ.

Odontology. 2018 Apr;106(2):125-134. doi: 10.1007/s10266-017-0310-9. Epub 2017 Jun 14.

PMID:
28616672
40.

Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure.

Jiménez-Ubieto A, Grande C, Caballero D, Yáñez L, Novelli S, Hernández-Garcia MT, Manzanares M, Arranz R, Ferreiro JJ, Bobillo S, Mercadal S, Galeo A, López Jiménez J, Moraleda JM, Vallejo C, Albo C, Pérez E, Marrero C, Magnano L, Palomera L, Jarque I, Martínez-Sánchez P, Martín A, Coria E, López-Guillermo A, Salar A, Lahuerta JJ.

Biol Blood Marrow Transplant. 2017 Oct;23(10):1631-1640. doi: 10.1016/j.bbmt.2017.05.021. Epub 2017 May 19.

41.

Amniotic membrane application for the healing of chronic wounds and ulcers.

Castellanos G, Bernabé-García Á, Moraleda JM, Nicolás FJ.

Placenta. 2017 Nov;59:146-153. doi: 10.1016/j.placenta.2017.04.005. Epub 2017 Apr 10.

PMID:
28413063
42.

Cytotoxicity of GuttaFlow Bioseal, GuttaFlow2, MTA Fillapex, and AH Plus on Human Periodontal Ligament Stem Cells.

Collado-González M, Tomás-Catalá CJ, Oñate-Sánchez RE, Moraleda JM, Rodríguez-Lozano FJ.

J Endod. 2017 May;43(5):816-822. doi: 10.1016/j.joen.2017.01.001. Epub 2017 Mar 23.

PMID:
28343929
43.

Analysis of the Adherence of Dental Pulp Stem Cells on Two-Dimensional and Three-Dimensional Silk Fibroin-Based Biomaterials.

Pecci-Lloret MP, Vera-Sánchez M, Aznar-Cervantes S, García-Bernal D, Sánchez RO, Pecci-Lloret MR, Moraleda JM, Cenis JL, Rodríguez-Lozano FJ.

J Craniofac Surg. 2017 Jun;28(4):939-943. doi: 10.1097/SCS.0000000000003596.

PMID:
28230598
44.

Cytotoxicity and bioactivity of various pulpotomy materials on stem cells from human exfoliated primary teeth.

Collado-González M, García-Bernal D, Oñate-Sánchez RE, Ortolani-Seltenerich PS, Álvarez-Muro T, Lozano A, Forner L, Llena C, Moraleda JM, Rodríguez-Lozano FJ.

Int Endod J. 2017 Dec;50 Suppl 2:e19-e30. doi: 10.1111/iej.12751. Epub 2017 Mar 17.

PMID:
28169432
45.

Silk-Fibroin and Graphene Oxide Composites Promote Human Periodontal Ligament Stem Cell Spontaneous Differentiation into Osteo/Cementoblast-Like Cells.

Vera-Sánchez M, Aznar-Cervantes S, Jover E, García-Bernal D, Oñate-Sánchez RE, Hernández-Romero D, Moraleda JM, Collado-González M, Rodríguez-Lozano FJ, Cenis JL.

Stem Cells Dev. 2016 Nov 15;25(22):1742-1754. Epub 2016 Aug 8.

PMID:
27503546
46.

Intervertebral Disc Repair by Allogeneic Mesenchymal Bone Marrow Cells: A Randomized Controlled Trial.

Noriega DC, Ardura F, Hernández-Ramajo R, Martín-Ferrero MÁ, Sánchez-Lite I, Toribio B, Alberca M, García V, Moraleda JM, Sánchez A, García-Sancho J.

Transplantation. 2017 Aug;101(8):1945-1951. doi: 10.1097/TP.0000000000001484.

PMID:
27661661
47.

Circulating aberrant plasma cells allows risk stratification of patients with myeloma.

Periago A, Campillo JA, Mrowiec A, Gimeno L, Montes NR, Martínez-Sánchez MV, Cabañas-Perianes V, García-Garay C, Bolarin JM, Blasco-Mogorrón A, Muro M, Berenguer M, Moraleda JM, García-Alonso AM, Minguela A.

Am J Hematol. 2016 Sep;91(9):E353-E355. doi: 10.1002/ajh.24431. Epub 2016 May 24. No abstract available.

48.

Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing.

Martínez-Sánchez MV, Periago A, Legaz I, Gimeno L, Mrowiec A, Montes-Barqueros NR, Campillo JA, Bolarin JM, Bernardo MV, López-Álvarez MR, González C, García-Garay MC, Muro M, Cabañas-Perianes V, Fuster JL, García-Alonso AM, Moraleda JM, Álvarez-Lopez MR, Minguela A.

Oncoimmunology. 2015 Oct 29;5(4):e1093721. eCollection 2016 Apr.

49.

Rett Syndrome Mutant Neural Cells Lacks MeCP2 Immunoreactive Bands.

Bueno C, Tabares-Seisdedos R, Moraleda JM, Martinez S.

PLoS One. 2016 Apr 11;11(4):e0153262. doi: 10.1371/journal.pone.0153262. eCollection 2016.

50.

Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS.

De La Serna J, Sanz J, Bermúdez A, Cabrero M, Serrano D, Vallejo C, Gómez V, Moraleda JM, Perez SG, Caballero MD, Conde E, Lahuerta JJ, Sanz G.

Bone Marrow Transplant. 2016 Jul;51(7):961-6. doi: 10.1038/bmt.2016.42. Epub 2016 Mar 7.

PMID:
26950372

Supplemental Content

Loading ...
Support Center